Skip to main content
Clinical Trials/NCT05973227
NCT05973227
Completed
Not Applicable

InTRaoperative Imaging DEvice Based on endogeNous opTical Properties to Evaluate Bowel Oxygenation in Colorectal Resections: Observational First-in-human Pilot Safety Trial -TRIDENT-

Intuitive Surgical1 site in 1 country10 target enrollmentJuly 6, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Left-sided Colorectal Resection : Diverticular Diseases
Sponsor
Intuitive Surgical
Enrollment
10
Locations
1
Primary Endpoint
image quality (sharpness, brightness, etc) and surgeon's feedback regarding the ergonomics and safety of Trident System v1.0 during surgery.
Status
Completed
Last Updated
last year

Overview

Brief Summary

The objective of the study is to assess the safety and technical feasibility of a new imaging system, used during colorectal resection surgery, named Trident in version 1.0, which could be used by the surgeon during colorectal procedures to obtain information on intestinal tissue oxygenation.

Detailed Description

This is a prospective, non-randomized, single center, feasibility trial. All consecutive patients that fulfil the inclusion/exclusion criteria will be informed about the possibility to be included in the present clinical investigation. Only subjects that have signed the study informed consent will be included in the study. The Trident System v1.0 will be used only during approximately 2 to 5 minutes during a precise surgical step, i.e., just before the final resection of the surgical specimen. Patients will be prospectively followed at 30 days post-surgery. Data will be collected prospectively from the medical records.

Registry
clinicaltrials.gov
Start Date
July 6, 2023
End Date
May 21, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient scheduled for a left-sided colorectal resection, irrespective of the surgical approach (open surgery, laparoscopic surgery,) because of:
  • Colon cancer OR
  • Sigmoid diverticular disease OR
  • Rectal cancer
  • All genders
  • Age \> 18 years old
  • Ability to understand the information related to the study protocol

Exclusion Criteria

  • Pregnancy or breastfeeding
  • Contraindications to anaesthesia
  • Inability to provide a written informed consent
  • Inclusion in a different ongoing clinical trial
  • Emergency procedure
  • Abdomino-perineal resection
  • Hartmann procedure
  • Patient is part of vulnerable population (e.g., prisoners, mentally disabled)

Outcomes

Primary Outcomes

image quality (sharpness, brightness, etc) and surgeon's feedback regarding the ergonomics and safety of Trident System v1.0 during surgery.

Time Frame: 30 days FU

descriptive analysis on the quality images by the engineering design team and feedback provided by clinical experts (surgeons) according to ad hoc form evaluating: 1) ergonomics aspects; 2) workflow; 3) risks of breaching sterility; 4) Speed of image acquisition.

Secondary Outcomes

  • - level of oxygenation (StO2) of the exteriorized colon before resection with the Trident System v1.0 - the level of oxygenation (StO2) provided by the system at the site chosen by the surgeon based on the clinical evaluation.(surgery day)

Study Sites (1)

Loading locations...

Similar Trials